Vol. 9 No. 1 (2013): January/February

Published: 01/01/2013

Articles

Associations between public health indicators and injecting prescription opioids by prescription opioid abusers in substance abuse treatment

Ryan A. Black, PhD, Kimberlee J. Trudeau, PhD, Theresa A. Cassidy, MPH, Simon H. Budman, PhD, Stephen F. Butler, PhD

5-17
- Requires Subscription or Fee PDF (USD 56)
Preliminary data on a new opioid risk assessment measure: The Brief Risk Interview

Ted Jones, PhD, Todd Moore, PhD

19-27
- Requires Subscription or Fee PDF (USD 56)
Hypoglycemia during rapid methadone dose escalation

Natalie Moryl, MD, Joan Pope, NP, Eugenie Obbens, MD, PhD

29-34
- Requires Subscription or Fee PDF (USD 56)
Comparison of efficacy between buprenorphine and tramadol in the detoxification of opioid (heroin)-dependent subjects

Jatinder Mohan Chawla, MD, Hemraj Pal, MD, Rakesh Lal, MD, Raka Jain, PhD, Nina Schooler, PhD, Yatan Pal Singh Balhara, MD

35-41
- Requires Subscription or Fee PDF (USD 56)
Open-label study to evaluate the efficacy and safety of extended-release hydromorphone in patients with chronic neuropathic pain

Srinivas Nalamachu, MD, Donna Ruck, ARNP, Rahul Nalamasu, Sam Fasbinder, Ritvik Bansal

43-49
- Requires Subscription or Fee PDF (USD 56)
Composite measure to assess efficacy/gastrointestinal tolerability of tapentadol ER versus oxycodone CR for chronic pain: Pooled analysis of randomized studies

Sanjay Merchant, PhD, David Provenzano, MD, Samir Mody, PharmD, MBA, Kai Fai Ho, PhD, Mila Etropolski, MD

51-61
- Requires Subscription or Fee PDF (USD 56)
Use of tincture of opium compared to oral morphine for the treatment of neonatal abstinence syndrome

Suzannah Kokotajlo, PharmD, Christine A. Robinson, PharmD, Amy Presti, MD, MSCR

62-70
- Requires Subscription or Fee PDF (USD 56)

Review Articles

Pharmacokinetic evaluation of hydrocodone/acetaminophen for pain management

Aarti Singla, MD, Paul Sloan, MD

71-80
- Requires Subscription or Fee PDF (USD 56)